Kosuke Ebina News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Patients receiving TNF, JAK, and CTLA4-Ig all demonstrated higher discontinuation rates due to ineffectiveness when compared to aIL-6R treatment.

Japan generalKosuke ebinaResearchgate kosuke ebinaDepartment of musculoskeletal regenerative medicineKansai consortium forMusculoskeletal regenerative medicineOsaka university facultyMedicine graduate schoolKansai consortiumRheumatic disease patients